The Taibo® Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.
More2017 President Shionogi Award - Two projects of Chang Ao won award
MoreNanjing Chang Ao Pharmaceutical Co., Limited organized a whip egg (a card game) competition on June 10, 2017.
MoreIn April of this year, a call for President Teshirogi Award (2017) was made as usual. And a call for posters for the recognition activities was made at the same time this year, and Mr. Jin from C&O designed and produced the poster.
MoreShenzhen, [September 29] C&O today announces the launch of its first next-generation proton pump inhibitor, Rabeprazole Sodium for Injection (Aobo Ping®), in China. Aubergine® is a self-developed product of C&O.
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account 
Mobile page